118 related articles for article (PubMed ID: 2724329)
1. Binding of complement component C5 to model immune complexes and the use of anti-C5 antibodies for determination of C5-containing circulating immune complexes.
Larsson A; Sjöquist J
J Clin Lab Immunol; 1989 Jan; 28(1):5-9. PubMed ID: 2724329
[TBL] [Abstract][Full Text] [Related]
2. Quantification of circulating immune complexes by chicken anti-C4 micro ELISA.
Larsson A; Sjöquist J
J Clin Lab Immunol; 1988 Sep; 27(1):39-43. PubMed ID: 3150766
[TBL] [Abstract][Full Text] [Related]
3. [Determination of circulating immune complexes and of their component immunoglobulin classes M, G, and A with a C1q-ELISA].
Sequeira Peña GA; Herrmann D; Vogt KH; Jäger L
Allerg Immunol (Leipz); 1991; 37(1):37-45. PubMed ID: 2063729
[TBL] [Abstract][Full Text] [Related]
4. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
Panush RS; Somberg LB; Katz P; Longley S
Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
[TBL] [Abstract][Full Text] [Related]
5. The detection of circulating immune complexes containing C1q and IgG using a new rapid serum ELISA test system.
Reckel RP; Harris J; Botsko E; Wellerson R; Varga S
Diagn Immunol; 1984; 2(4):228-37. PubMed ID: 6335421
[TBL] [Abstract][Full Text] [Related]
6. Potential pathogenicity of deglycosylated IgG cross reactive with streptokinase and fibronectin in the serum of patients with rheumatoid arthritis.
Cuchacovich M; Gatica H; Grigg DM; Pizzo SV; Gonzalez-Gronow M
J Rheumatol; 1996 Jan; 23(1):44-51. PubMed ID: 8838507
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series.
Wager O; Lindström P; Räsänen JA; Kekomäki R; Ziola B; Salmi A; Isomäki H; Skrifvars B; Penttinen K
Clin Exp Immunol; 1981 Oct; 46(1):149-60. PubMed ID: 7337967
[TBL] [Abstract][Full Text] [Related]
8. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
9. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
[TBL] [Abstract][Full Text] [Related]
10. Studies of circulating immune complexes in ankylosing spondylitis.
Kinsella TD; Lanteigne C; Lewkonia RM; Fritzler MJ
Clin Invest Med; 1982; 5(4):223-30. PubMed ID: 7160109
[TBL] [Abstract][Full Text] [Related]
11. [Use of solid-phase Clq-ELISA for detecting circulating immune complexes in human diseases].
Aleshkin VA; Nasonov EL; Eremeeva MV; Kobylianskiĭ AG
Ter Arkh; 1989; 61(6):113-6. PubMed ID: 2477907
[TBL] [Abstract][Full Text] [Related]
12. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
Larsson A; Sjöquist J
J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
[TBL] [Abstract][Full Text] [Related]
13. Immunochemical analyses of components of immune complexes in the sera of patients with autoimmune diseases.
Ferraccioli G; Karsh J; Osterland CK
J Rheumatol; 1983 Dec; 10(6):881-8. PubMed ID: 6663592
[TBL] [Abstract][Full Text] [Related]
14. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
[TBL] [Abstract][Full Text] [Related]
15. Circulating immune complexes and rheumatoid arthritis.
Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
[TBL] [Abstract][Full Text] [Related]
16. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
[TBL] [Abstract][Full Text] [Related]
17. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
[TBL] [Abstract][Full Text] [Related]
18. Circulating immune complexes in rheumatoid arthritis: a prospective study using five immunoassays.
Reynolds WJ; Yoon SJ; Emin M; Chapman KR; Klein MH
J Rheumatol; 1986 Aug; 13(4):700-6. PubMed ID: 3490573
[TBL] [Abstract][Full Text] [Related]
19. A polyclonal IgM-RF enzyme-linked immunosorbent assay for the detection of circulating immune complexes.
Bukh A; Thomsen BS; Kimose HH; Nielsen LR; Svehag SE; Møller NP
J Clin Lab Immunol; 1988 Aug; 26(4):195-200. PubMed ID: 3199429
[TBL] [Abstract][Full Text] [Related]
20. Binding to histone of an anomalous IgG from patients with SLE and drug-induced lupus.
Teodorescu M; Ustiyan V; Russo K; Rubin RL
Clin Immunol; 2004 Feb; 110(2):145-53. PubMed ID: 15003811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
